Cibus, Inc.
About Cibus, Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $3.6M
- Net income
- -$127.1M
- Total assets
- $305.0M
- Market cap
- $98.5M
- Operating margin
- -6062.8%
- Net margin
- -6633.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $4.3M
- Operating expenses
- $262.7M
- Operating income
- -$258.4M
- Income tax
- $29.0K
- Net income
- -$282.7M
- EPS (basic)
- $-10.83
- EPS (diluted)
- $-10.83
Balance sheet
- Total assets
- $350.1M
- Current assets
- $16.9M
- Total liabilities
- $252.2M
- Current liabilities
- $19.9M
- Shareholders’ equity
- $92.2M
Cash flow
- Operating cash flow
- -$58.0M
- Investing cash flow
- -$808.0K
- Financing cash flow
- $40.6M
- Net cash flow
- -$18.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $98.5M
- EPS (diluted)
- $-10.83
- Shares outstanding
- 80.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 20, 2017
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $127.1M in FY2025.
- Revenue grew 135% from FY2023 to FY2024.
- Trading 70% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Cibus, Inc..
Write a review
News about Cibus, Inc.
News & sentiment via Polygon.io
